Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study
Clinical trial NCT02636426 · COMPLETED
Trial details
- NCT number
- NCT02636426
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-12-27
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.